Related references
Note: Only part of the references are listed.Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China
Yutong He et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer
D. Wang et al.
SEMINARS IN CANCER BIOLOGY (2017)
Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation
Kai Qu et al.
SCIENTIFIC REPORTS (2017)
Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer
Y. Zhou et al.
CANCER GENE THERAPY (2017)
Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries
Hongmei Zeng et al.
THORACIC CANCER (2016)
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database
Smita Sihag et al.
ANNALS OF THORACIC SURGERY (2016)
miR-21 predicts poor prognosis in patients with osteosarcoma
Xianfeng Ren et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer
Juan Liao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Prognostic role of microRNA-21 expression in gliomas: a meta-analysis
Chao Li et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma A Consort Study
Xianglian Ding et al.
MEDICINE (2016)
MicroRNA-21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa
Haibin Sun et al.
MOLECULAR MEDICINE REPORTS (2016)
The Sequence and Structure Determine the Function of Mature Human miRNAs
Katarzyna Rolle et al.
PLOS ONE (2016)
Significance of microRNA 21 in gastric cancer
Durairaj Sekar et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol
Arezoo Rasti et al.
BMJ OPEN (2016)
Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: A meta-analysis
Wei Yu et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis
John Zeng Hong Li et al.
CHINESE JOURNAL OF CANCER (2016)
Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer
Mette Winther et al.
ACTA ONCOLOGICA (2015)
Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
Zhike Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma
Andrew M. Kaz et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)
Characterization and effects of miR-21 expression in esophageal cancer
S. -W. Wen et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis
S. R. Yan et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Advances in curatively intended treatment
Jesper Lagergren
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Programmed Cell Death 4 and MicroRNA 21 Inverse Expression Is Maintained in Cells and Exosomes From Ovarian Serous Carcinoma Effusions
Rocco Cappellesso et al.
CANCER CYTOPATHOLOGY (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
Youhei Tanaka et al.
CANCER (2013)
Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma
Xiong Liu et al.
CANCER BIOLOGY & THERAPY (2013)
Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer
Pei Li et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
Simon Kjaer Hermansen et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma
Nazila Nouraee et al.
PLOS ONE (2013)
Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis
M. Fassan et al.
DISEASES OF THE ESOPHAGUS (2012)
Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma
Junji Kurashige et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
Xiao-Guang Liu et al.
MEDICAL ONCOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
Yukiharu Hiyoshi et al.
CLINICAL CANCER RESEARCH (2009)
Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors
Svetlana V. Kalinichenko et al.
LUNG CANCER (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
Lisa B. Frankel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation
HS Yang et al.
ONCOGENE (2001)
Share Paper
